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Abstract
Background: Primary care-givers of children with autism spectrum disorder (ASD) or intellectual 
disability (ID) have poorer health and quality of lifethan primary care-givers of typically developing 
children. We aimed to review original research which described factors impacting the health of care-givers 
of children with ASD or ID and to discuss how these factors might influence care-giver health. 
Methods: We searched electronic databases and retrieved 33 relevant research articles.
Results: Factors impacting care-giver health included child behaviour, support and diagnostic issues. We 
explain how these factors might impact care-giver health and how they might act differentially in care-
givers of children with different types of ASD or ID. Interventions to moderate one or more risk factors 
could pave the way for improved care-giver health. 
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Introduction
A person with autism spectrum disorder (ASD) has a life-long 
neuro-developmental disability which is diagnosed by severe 
deficits in social communication and interaction, along with 
restricted or repetitive behaviour and interests [1]. Intellectual 
disability (ID) is diagnosed in persons with an IQ below 70 along 
with impairments in adaptive functioning both of which must 
be present before 18 years [1]. The prevalence of ASD varies 
between countries with a median of about 60 per 10,000 [2] 
while the prevalence of ID is higher at 104 per 10,000 [3].
There is a general consensus among researchers that Qual-
ity of Life (QoL) incorporates measures of physical functioning, 
mental health and engagement in social interaction [4]. A 
plethora of research has identified poorer health and QoL in 
the primary care-givers (here after referred to as care-givers) 
of children with ASD or ID than in other care-givers [5-11]. For 
example, using linked data, we demonstrated that in the years 
after their child’s birth, mothers of children with ASD or ID had 
higher rates of psychiatric disorders than other mothers [9,10]. 
Furthermore, we also identified health differentials in mothers of 
children with different sub-types of ASD or ID [12]. Using the12 
Item Short Form Health Survey (SF-12), parents of children with 
ASD without ID were also reported as experiencing lower QoL 
and more stress than parents of children with ASD with ID [7]. 
Moreover, mothers of children with ASD had more self-reported 
anxiety and depression than mothers of children with Down 
syndrome [13]. Care-giver health issues challenge a family’s 
QoL and may impact the care and healthy development of all 
children within the family [14,15]. Identifying risk factors for 
care-givers of children with a particular developmental disor-
der would enable the identification of groups whose health 
is especially vulnerable. In addition, identifying both risk and 
protective factors would enable a better understanding of 
the health trajectories of care-givers of children with ASD or 
ID. In such ways, informed interventions and services might 
be developed to assist in optimising care-giver health. There-
fore, we aimed to review the research literature in the area of 
care-giver health, ASD and ID to locate original research which 
described risk and/or protective factors for health in mothers 
of children with ASD or ID. Our second aim was to discuss how 
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these factors might influence care-giver health.
Methods of the review
We searched the electronic databases, Web of Knowledge, 
Medline, Scopus and Google Scholar, using combinations of 
the following groups of search terms associated with ASD 
and ID along with care-giver health. These included terms 
which are related to:
t ASD, ID or sub-groups such as autism, autistic, pervasive 
development disorder,intellectual disability, mental retarda-
tion, disability, disabled, Down, Asperger;
t Health such as health, depression, physical, mental, psychi-
atric, psychological, phenotype, quality of life, well-being;
t Care-givers such as mothers, parents, care*.
We included an original paper in our review if it:
t Was published between 1st January 1990 and 31st De-
cember, 2016
t Described original research in a peer-reviewed article 
which was written in English
t Used a study population of 15 persons or more
t Described arisk or protective factor for poorer health in 
mothers, parents or care-givers of a child with ASD or ID 
or a sub-type (such as ASD with ID or Down syndrome) 
Using research [16,17], we developed a simple and objective 
five-level tool to assess the strength of evidence provided by 
the papers in this review (Table 1).
Results
We retained 33 articles. Table 2 summarizes each paper, pro-
viding an assessment of the quality of evidence, methods of 
data collection, recruitment, country of origin, study popu-
lation, comparison group and the strength of the assessed 
relationship or a key result.
Discussion
In the first section, we discuss the papers retrieved for the 
review according to the reported risk or protective factors 
for poorer care-giver health or QoL. In the second section, 
we examine care-giver health disparities according to the 
child’s diagnosis and the likely impact of particular risk or 
protective factors. The final section examines how risk and 
protective factors might impact the health of care-givers of 
children with ASD or ID. 
Challenging child behavior
Challenging child behaviour, the most commonly identified 
risk factor for poorer care-giver health and QoL outcomes, 
was reported in ten of the 33 studies. Researchers provided 
substantial evidence that the social impact of the child’s 
disability [18] and challenging behaviours [19-25] in chil-
dren with ASD or ID was associated with poorer care-giver 
mental health. At the same level of evidence, challenging 
child behaviours in children with ID were related to poorer 
care-giver physical health in subsequent years [26]. The total 
score for the Jenkins Behaviour Questionnaire was higher 
in children with care-givers having two or more symptoms 
of depression [P=0.004] [27]. Symptoms of anxiety (P=0.06) 
and stress (P=0.08) were related also to challenging child 
behaviour though the associations did not reach statistical 
significance. These associations were pre dominantly due to 
issues of discipline (control, tantrums, demanding attention) 
and disturbances insleep [27].
Challenging child behaviours had a negative effect on 
care-giver and family QoL. One research group administered 
the Parental-Developmental Disorders-Quality of Life Scale 
(Par–DD-QoL)to the parents of children with ASD and pro-
vided weak evidence that challenging child behaviour was 
an independent risk factor for poorer QoL [28]. Results from 
a qualitative study were similar [24]. 
Level of support 
Support networks were associated with improved care-giver 
health and QoL in families of a child with ASD or ID. For ex-
ample, substantial evidence indicated that family support 
reduced care-giver burden in families with a child with ASD 
[20,29] and that family and neighbourhood support was 
associated with improved parental mental health [20,30,31] 
and reduced parental aggravation or irritability [32]. Further 
substantial evidence [33] [as classified by our descriptors on 
Table 1] was provided using the Multidimensional Scale of 
Perceived Social Support (MSPSS) which indicated that greater 
social support was associated with lower levels of individual 
distress (apart from anxiety and depression) in the families 
of children with ASD [25]. Alternatively, substantial evidence 
demonstrated that mothers of children with ASD had poorer 
mental health than other mothers but no less social support 
for parenting [34]. 
Higher levels of support had a similar favourable effect 
Level of evidence Narrow descriptor Broader descriptor Description of study
5 Strong
Substantial
Validated scores & magnitude of efect assessed 
4 Moderate Validated scores but no magnitude of efect assessed
3 Mild Magnitude of efect assessed but no validated scores 
2 Weak Less substantial No validated scores or assessment of magnitude of efect
1 Indication only Descriptive study
Table 1. Assessment of level of evidence.
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on parents with a child with ID [31-34]. Using the SF-12, an 
Australian study [35] provided substantial evidence (as defined 
in Table 1) that better mental health in parents older than 60 
years was associated with having a partner and a large and 
supportive network of family, friends and neighbours. Oth-
ers [36] used the Beck Depression Inventory and reported 
that single mothers living with a child with ID were more 
depressed than similar mothers living with a partner. There 
is also substantial evidence that poorer physical health in 
female care-givers of adults with developmental disabilities 
was associated with a lack of services [37] and that the effect 
of stress on physical health was moderated by parental social 
support [38].
Socio-economic status
Higher socio-economic status (SES) was a protective factor 
for parental health and particularly maternal health [39-41]. 
For example, correlational analyses showed that parents of 
children with ASD with higher incomes had less distress and 
an improved QoL compared with those of lower incomes [41]. 
Similarly, there was strong evidence that socio-economically 
disadvantaged mothers had a greater risk of a psychiatric 
disorder than socio-economically advantaged mothers with 
a child with a similar disability [39,40]. 
Rewards and stigma
In a comparison of mothers of children with Down syndrome 
(n=21) and mothers of children with ASD (n=17), researchers 
provided some evidence of greater attachment and gratifica-
tion in the mothers of children with Down syndrome [42]. A 
case-control study, with a lower evidence-base [43], reported 
that mothers of children with Down syndrome felt more 
rewarded by parenting than mothers of children with other 
developmental disabilities.
Affiliate stigma (or self-stigmatization) was higher among 
care-givers of persons with ASD compared to care-givers of 
persons with ID or physical disabilities although the level of 
evidence was not strong [44]. There was also evidence that 
there was additional societal stigma towards the care-givers 
of children who appear normal but manifest abnormal be-
haviours [45].
 
Diagnostic issues
Diagnostic uncertainty and an unclear prognosis are factors 
which can cause the greatest concern to care-givers of chil-
dren with ASD and those for whom a cause of their child’s ID 
has not been identified [45-47]. The first of these studies [45] 
used a combination of interviews or focus groups with care-
givers and the second [46] provided qualitative evidence by 
interviewing care-givers. In the third [47], German researchers 
compared the mothers of children with Down syndrome, ID 
of unknown cause and typically developing children with 
respect to anxiety, guilt and emotional burden using the 
state-Trait-Anxiety-Inventory and the Balanced Inventory of 
Desirable Responding. They concluded that uncertainty was 
a major cause of stress in mothers of children with ID of 
unknown cause [47]. A fourth study used the Ulm Quality of 
Life Inventory for Parents to examine the QoL of parents of a 
child with a developmental disability before genetic testing 
and after receiving a genetic cause for their child’s disability.
The results provided strong evidence that maternal QoL was 
improved once the underlying diagnosis was known [48].
Broad Autism Phenotype
The concept of mild autistic traits in the relatives of a person 
with ASD is termed the Broad Autism Phenotype [49]. Validated 
questionnaires such as the Autism Spectrum Quotient [50] and 
the Broad Autism phenotype questionnaire [51] are used to 
quantify the extent of this trait on a linear scale. Two research 
groups [30,52] provided mild and weak levels of evidence that 
persons exhibiting the Broad Autism Phenotype were at an 
increased risk of depression.
Maternal health by the child’s diagnosis or sub-type and 
the impact of risk factors
In a previous review [12], we found that mothers of children 
with Down syndrome generally had better health than moth-
ers of children with other intellectual disabilities. In turn, 
mothers of children with intellectual disabilities other than 
Down syndrome, generally had better health than mothers 
of children with ASD [especially ASD without ID] (Figure 1). 
The disparities in the health of care-givers of children with 
ASD or ID may be partially explained by child characteris-
tics associated with the particular diagnostic category. For 
example, challenging behaviours occur more often and are 
usually more severe in children with ASD than children with 
Down syndrome [53]. Thus, a commonly cited risk factor for 
poorer care-giver health and QoL outcomes, challenging child 
behaviour, is more often associated with ASD than Down 
syndrome. The increased likelihood of parents of children 
with ASD manifesting a Broad Autism Phenotype and its as-
sociation with depression [30,52] could explain why poorer 
Figure 1. Assessment of the health of care-givers of 
children with ASD or ID.
ID, intellectual disability; ASD, autism spectrum disorder 
Figure adapted from Fairthorne et al. [12].
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mental health is more common in parents of children with 
ASD than in parents of children with other developmental 
disabilities. Furthermore, personality type influences a per-
son’s willingness to seek support [54]. Hence, the lower social 
support evidenced in families with a child with ASD could be 
mediated by parental personality traits which are associated 
with the Broad Autism Phenotype. The consequent overall 
reduction in social support could thereby further increase 
the risk of poorer mental health in these parents. Moreover, 
the lag-time to diagnosis in comparison to Down syndrome, 
where children are diagnosed at birth, could also impact 
negatively on the mental health of parents of children with 
ASD. Furthermore, mothers of children with Down syndrome 
mostly reported that parenting was more fulfilling than did 
mothers of children with other disorders [42]. In contrast, care-
givers of children with ASD were the most negatively affected 
by stigma [44], a risk factor for care-giver health. Moreover, 
Down syndrome is the most common genetic form of ID and 
children are readily recognised and supported by members 
of the community due to their distinctive phenotype [55]. On 
the other hand, children with ASD have no distinguishing 
phenotype and mostly appear physically normal to commu-
nity bystanders [56]. Thus, there is the expectation that their 
behaviour would be normal which may not be the case [45]. 
How risk and protective factors might impact care-
giver health
We have identified a total of seven risk or protective factors 
for health and QoL in the care-givers of children with ASD or 
ID. The impact of challenging child behaviour seems likely to 
be mediated by the increased parental stress generated by 
antisocial, and the sometimes dangerous and self-limiting 
behaviours in the child [57]. Challenging antisocial child be-
haviours such as running away and self-injurious behaviour 
such as head-banging can also severely limit family activities 
and thereby increase family social isolation [58]. Addition-
ally, antisocial behaviour, when unexpected by the outsider, 
could further exacerbate the stigmatisation of parents [59]. 
Increased levels of extended family support and other support 
given to parents and their family were positively associated 
with parental well-being [20,30,31]. Support provides relief 
for care-givers and in so doing provides opportunities for 
respite and thus engagement in social activities which might 
normally be reduced in care-givers of children with ASD or ID 
[54]. Socio-economic status may further impact on care-giver 
health since only well-resourced families may be able to gain 
support by enlisting paid care-givers and respite. Research 
has also found that families of lower SES have less knowledge 
of available support [60] and this may be because they are 
not equipped with the skills or assertiveness to navigate the 
systems. 
Parents of children without a diagnosis for their disability 
can be disadvantaged [61] by the resultant lack ofanticipa-
tory and reproductive guidance, along with support by net-
working with parents of children with a similar diagnosis. 
Furthermore, these parents may feel ongoing pressure to 
search for a cause for their child’s condition when either there 
is no clear aetiology or a lack of available technology to test 
a plausible diagnosis [47]. For example, the CDKL5 disorder 
is a genetic condition causing severe neuro-developmental 
impairment and refractory epilepsy from infancy [62]. Unfor-
tunately, in Western Australia (along with many other cities in 
the Western world), genetic testing to confirm a diagnosis is 
not currently available. Such issues might negatively impact 
care-giver health.
Summary and implications
Care-givers of children with ASD are more likely to experi-
ence many of the risk factors and less likely to experience 
the protective factors we identified as contributing to poorer 
mental health. Interventions to reduce risk factors and increase 
protective factors could pave the way for improved care-giver 
health. For example, workshops to train parents to better 
manage challenging behaviours in their children and earlier 
diagnosis of ASD (and particularly ASD without ID) would 
seem likely to improve parental wellbeing. Similarly, helping 
to expand support networks might reduce care-giver burden 
and stress leading to improved health. High SES is a protec-
tive factor for care-giver health. Hence, increased subsidised 
supports for those of low SES, such as care-giver respite and 
home help, might also assist care-givers of children with ASD 
or ID to maintain their health.  
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Publication history
Editor: Mohammad H. Hadadzadeh, Wheeling Jesuit University, USA.
Received: 12-Oct-2017 Final Revised: 12-Dec-2017
Accepted: 18-Dec-2017 Published: 
Authors’ contributions JF YM HL
Research concept and design ✓ -- --
Collection and/or assembly of data ✓ -- --
Data analysis and interpretation ✓ -- --
Writing the article ✓ -- --
Critical revision of the article ✓ ✓ ✓
Final approval of article ✓ ✓ ✓
Statistical analysis -- -- --
References
1. ŵĞƌŝĐĂŶWƐǇĐŚŝĂƚƌŝĐƐƐŽĐŝĂƟŽŶ ?ŝĂŐŶŽƐƟĐĂŶĚƐƚĂƟƐƟĐĂůŵĂŶƵĂůŽĨ
ŵĞŶƚĂůĚŝƐŽƌĚĞƌƐŵĞƌŝĐĂŶWƐǇĐŚŝĂƚƌŝĐWƵďůŝƐŚŝŶŐ. 2013. 
2. Fairthorne JC. DŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƚǇŽƌĂƵƟƐŵ
ƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ PƉƌĞ ?ĞǆŝƐƟŶŐĚŝīĞƌĞŶĐĞƐ ?ŚĞĂůƚŚĂŶĚƋƵĂůŝƚǇŽĨůŝĨĞ. 
2014. 
3. Maulik PK, Mascarenhas MN, Mathers CD, Dua T and Saxena S.
WƌĞǀĂůĞŶĐĞŽĨŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƚǇ PĂŵĞƚĂ ?ĂŶĂůǇƐŝƐŽĨƉŽƉƵůĂƟŽŶ ?
ďĂƐĞĚƐƚƵĚŝĞƐ. Res Dev Disabil. 2011; 32:419-36. | Aritcle | PubMed 
Fairthorne et al., Journal of Autism 2017, 
http://www.hoajonline.com/journals/pdf/2054-992X-4-2.pdf
7
doi: 
4. Post MW.ĞĮŶŝƟŽŶƐŽĨƋƵĂůŝƚǇŽĨůŝĨĞ PǁŚĂƚŚĂƐŚĂƉƉĞŶĞĚĂŶĚŚŽǁ
ƚŽŵŽǀĞŽŶ. Top Spinal Cord Inj Rehabil. 2014; 20:167-80. | Aritcle | 
PubMed Abstract | PubMed FullText
5. Miodrag N and Hodapp RM.ŚƌŽŶŝĐƐƚƌĞƐƐĂŶĚŚĞĂůƚŚĂŵŽŶŐƉĂƌĞŶƚƐ
ŽĨĐŚŝůĚƌĞŶǁŝƚŚŝŶƚĞůůĞĐƚƵĂůĂŶĚĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐĂďŝůŝƟĞƐ. Curr Opin 
Psychiatry. 2010; 23:407-11. | Aritcle | PubMed 
6. dŽƚƐŝŬĂs ?,ĂƐƟŶŐƐZW ?ŵĞƌƐŽŶ ?>ĂŶĐĂƐƚĞƌ'ĂŶĚĞƌƌŝĚŐĞD ?
ƉŽƉƵůĂƟŽŶ ?ďĂƐĞĚŝŶǀĞƐƟŐĂƟŽŶŽĨďĞŚĂǀŝŽƵƌĂůĂŶĚĞŵŽƟŽŶĂůƉƌŽďůĞŵƐ
ĂŶĚŵĂƚĞƌŶĂůŵĞŶƚĂůŚĞĂůƚŚ PĂƐƐŽĐŝĂƟŽŶƐǁŝƚŚĂƵƟƐŵƐƉĞĐƚƌƵŵ
ĚŝƐŽƌĚĞƌĂŶĚŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƚǇ. J Child Psychol Psychiatry. 2011; 
52:91-9. | Aritcle | PubMed 
7. ůůŝŬ, ?>ĂƌƐƐŽŶ:KĂŶĚ^ŵĞĚũĞ, ?,ĞĂůƚŚ ?ƌĞůĂƚĞĚƋƵĂůŝƚǇŽĨůŝĨĞŝŶƉĂƌĞŶƚƐ
ŽĨƐĐŚŽŽů ?ĂŐĞĐŚŝůĚƌĞŶǁŝƚŚƐƉĞƌŐĞƌ^ǇŶĚƌŽŵĞŽƌ,ŝŐŚ ?&ƵŶĐƟŽŶŝŶŐ
ƵƟƐŵ. Health Qual Life Outcomes. 2006; 4:1. | Aritcle | PubMed 
Abstract | PubMed FullText
8. ^ŝŶŐĞƌ', ?DĞƚĂ ?ĂŶĂůǇƐŝƐŽĨĐŽŵƉĂƌĂƟǀĞƐƚƵĚŝĞƐŽĨĚĞƉƌĞƐƐŝŽŶŝŶ
ŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂŶĚǁŝƚŚŽƵƚĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐĂďŝůŝƟĞƐ. Am J 
Ment Retard. 2006; 111:155-69. | Aritcle | PubMed 
9. &ĂŝƌƚŚŽƌŶĞ: ?:ĂĐŽďǇW ?ŽƵƌŬĞ: ?ĚĞ<ůĞƌŬEĂŶĚ>ĞŽŶĂƌĚ, ?KŶƐĞƚŽĨ
ŵĂƚĞƌŶĂůƉƐǇĐŚŝĂƚƌŝĐĚŝƐŽƌĚĞƌƐĂŌĞƌƚŚĞďŝƌƚŚŽĨĂĐŚŝůĚǁŝƚŚĂƵƟƐŵ
ƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ PƌĞƚƌŽƐƉĞĐƟǀĞĐŽŚŽƌƚƐƚƵĚǇ. ƵƟƐŵ. 2016; 20:37-
44. | Aritcle | PubMed 
10. &ĂŝƌƚŚŽƌŶĞ: ?:ĂĐŽďǇW ?ŽƵƌŬĞ: ?ĚĞ<ůĞƌŬEĂŶĚ>ĞŽŶĂƌĚ, ?KŶƐĞƚŽĨ
ŵĂƚĞƌŶĂůƉƐǇĐŚŝĂƚƌŝĐĚŝƐŽƌĚĞƌƐĂŌĞƌƚŚĞďŝƌƚŚŽĨĂĐŚŝůĚǁŝƚŚŝŶƚĞůůĞĐƚƵĂů
ĚŝƐĂďŝůŝƚǇ PĂƌĞƚƌŽƐƉĞĐƟǀĞĐŽŚŽƌƚƐƚƵĚǇ. J Psychiatr Res. 2015; 61:223-30. 
| Aritcle | PubMed 
11. 'ŝĂůůŽZ ?tŽŽĚ ?:ĞůůĞƩZĂŶĚWŽƌƚĞƌZ ?&ĂƟŐƵĞ ?ǁĞůůďĞŝŶŐĂŶĚƉĂƌĞŶƚĂů
ƐĞůĨ ?ĞĸĐĂĐǇŝŶŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂŶĂƵƟƐŵƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ. 
ƵƟƐŵ. 2013; 17:465-80. | Aritcle | PubMed 
12. &ĂŝƌƚŚŽƌŶĞ: ?ĚĞ<ůĞƌŬEĂŶĚ>ĞŽŶĂƌĚ, ?,ĞĂůƚŚŽĨŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶ
ǁŝƚŚŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƚǇŽƌĂƵƟƐŵƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ PĂƌĞǀŝĞǁŽĨƚŚĞ
ůŝƚĞƌĂƚƵƌĞ. Medical Research Archives. 2015; 3:1-21. 
13. WŝǀĞŶ: ?ŚĂƐĞ' ?>ĂŶĚĂZ ?tǌŽƌĞŬD ?'ĂǇůĞ: ?ůŽƵĚĂŶ&ŽůƐƚĞŝŶ^ ?
WƐǇĐŚŝĂƚƌŝĐĚŝƐŽƌĚĞƌƐŝŶƚŚĞƉĂƌĞŶƚƐŽĨĂƵƟƐƟĐŝŶĚŝǀŝĚƵĂůƐ. J Am Acad 
Child Adolesc Psychiatry. 1991; 30:471-8. | Aritcle | PubMed 
 ? ? ?DĂƚĞƌŶĂůĚĞƉƌĞƐƐŝŽŶĂŶĚĐŚŝůĚĚĞǀĞůŽƉŵĞŶƚ. Paediatr Child Health. 
2004; 9:575-598. | PubMed Abstract | PubMed FullText
15. tĂůŬĞƌ^W ?tĂĐŚƐd ?'ĂƌĚŶĞƌ:D ?>ŽǌŽī ?tĂƐƐĞƌŵĂŶ' ?WŽůůŝƩ 
and Carter JA.ŚŝůĚĚĞǀĞůŽƉŵĞŶƚ PƌŝƐŬĨĂĐƚŽƌƐĨŽƌĂĚǀĞƌƐĞŽƵƚĐŽŵĞƐŝŶ
ĚĞǀĞůŽƉŝŶŐĐŽƵŶƚƌŝĞƐ. Lancet. 2007; 369:145-57. | Aritcle | PubMed 
16. tĞƐƚ^ ?<ŝŶŐs ?ĂƌĞǇd ?>ŽŚƌ< ?DĐ<ŽǇEĂŶĚ^ƵƩŽŶ^ĞƚĂů ?^ǇƐƚĞŵƐƚŽ
ƌĂƚĞƚŚĞƐƚƌĞŶŐƚŚŽĨƐĐŝĞŶƟĮĐĞǀŝĚĞŶĐĞ ?ĞǀŝĚĞŶĐĞƌĞƉŽƌƚ ?ƚĞĐŚŶŽůŽŐǇ
ĂƐƐĞƐƐŵĞŶƚŶŽ ? ? ?ǀŝĚĞŶĐĞZĞƉŽƌƚ ?dĞĐŚŶŽůŽŐǇƐƐĞƐƐŵĞŶƚEŽ ? ?
 ?WƌĞƉĂƌĞĚďǇƚŚĞZĞƐĞĂƌĐŚdƌŝĂŶŐůĞ/ŶƐƟƚƵƚĞ ?hŶŝǀĞƌƐŝƚǇŽĨEŽƌƚŚ
ĂƌŽůŝŶĂǀŝĚĞŶĐĞ ?ďĂƐĞĚWƌĂĐƟĐĞĞŶƚĞƌƵŶĚĞƌŽŶƚƌĂĐƚEŽ ? ? ? ? ? ? ?
0011). 2002. 
17. ŝůůŽŶ^Z ?ĚĂŵƐ ?'ŽƵĚǇ> ?ŝƩŶĞƌDĂŶĚDĐEĂŵĂƌĂ^ ?ǀĂůƵĂƟŶŐ
ǆĞƌĐŝƐĞĂƐǀŝĚĞŶĐĞ ?ĂƐĞĚWƌĂĐƟĐĞĨŽƌ/ŶĚŝǀŝĚƵĂůƐǁŝƚŚƵƟƐŵ
^ƉĞĐƚƌƵŵŝƐŽƌĚĞƌ. Front Public Health. 2016; 4:290. | Aritcle | PubMed 
Abstract | PubMed FullText
18. ŵĞƌƐŽŶ ?DŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶĂŶĚĂĚŽůĞƐĐĞŶƚƐǁŝƚŚŝŶƚĞůůĞĐƚƵĂů
ĚŝƐĂďŝůŝƚǇ PƐŽĐŝĂůĂŶĚĞĐŽŶŽŵŝĐƐŝƚƵĂƟŽŶ ?ŵĞŶƚĂůŚĞĂůƚŚƐƚĂƚƵƐ ?ĂŶĚƚŚĞ
ƐĞůĨ ?ĂƐƐĞƐƐĞĚƐŽĐŝĂůĂŶĚƉƐǇĐŚŽůŽŐŝĐĂůŝŵƉĂĐƚŽĨƚŚĞĐŚŝůĚ ?ƐĚŝĸĐƵůƟĞƐ. J 
Intellect Disabil Res. 2003; 47:385-99. | Aritcle | PubMed 
19. ŽƵƌŬĞ: ?ZŝĐĐŝĂƌĚŽ ?ĞďďŝŶŐƚŽŶ ?ŝďĞƌƟ< ?:ĂĐŽďǇW ?ǇŬĞW ?DƐĂůů
D ?ŽǁĞƌĂŶĚ>ĞŽŶĂƌĚ, ?WŚǇƐŝĐĂůĂŶĚŵĞŶƚĂůŚĞĂůƚŚŝŶŵŽƚŚĞƌƐŽĨ
ĐŚŝůĚƌĞŶǁŝƚŚŽǁŶƐǇŶĚƌŽŵĞ. J Pediatr. 2008; 153:320-6. | Aritcle | 
PubMed Abstract | PubMed FullText
20. ƌŽŵůĞǇ: ?,ĂƌĞ: ?ĂǀŝƐŽŶ<ĂŶĚŵĞƌƐŽŶ ?DŽƚŚĞƌƐƐƵƉƉŽƌƟŶŐ
ĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐƟĐƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌƐ PƐŽĐŝĂůƐƵƉŽƌƚ ?ŵĞŶƚĂůŚĞĂůƚŚ
ƐƚĂƚƵƐĂŶĚƐĂƟƐĨĂĐƟŽŶǁŝƚŚƐĞƌǀŝĐĞƐ. ƵƟƐŵ. 2004; 8:409-23. | Aritcle | 
PubMed 
21. ƐƚĞƐ ?DƵŶƐŽŶ: ?ĂǁƐŽŶ' ?<ŽĞŚůĞƌ ?ŚŽƵy,ĂŶĚďďŽƩZ ?
WĂƌĞŶƟŶŐƐƚƌĞƐƐĂŶĚƉƐǇĐŚŽůŽŐŝĐĂůĨƵŶĐƟŽŶŝŶŐĂŵŽŶŐŵŽƚŚĞƌƐŽĨ
ƉƌĞƐĐŚŽŽůĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐŵĂŶĚĚĞǀĞůŽƉŵĞŶƚĂůĚĞůĂǇ. ƵƟƐŵ. 2009; 
13:375-87. | Aritcle | PubMed Abstract | PubMed FullText
22. Firth I and Dryer R.dŚĞƉƌĞĚŝĐƚŽƌƐŽĨĚŝƐƚƌĞƐƐŝŶƉĂƌĞŶƚƐŽĨĐŚŝůĚƌĞŶǁŝƚŚ
ĂƵƟƐŵƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ. J Intellect Dev Disabil. 2013; 38:163-71. | 
Aritcle | PubMed
23. ,ĞƌƌŝŶŐ^ ?'ƌĂǇ< ?dĂīĞ: ?dŽŶŐĞ ?^ǁĞĞŶĞǇĂŶĚŝŶĨĞůĚ^ ?ĞŚĂǀŝŽƵƌ
ĂŶĚĞŵŽƟŽŶĂůƉƌŽďůĞŵƐŝŶƚŽĚĚůĞƌƐǁŝƚŚƉĞƌǀĂƐŝǀĞĚĞǀĞůŽƉŵĞŶƚĂů
ĚŝƐŽƌĚĞƌƐĂŶĚĚĞǀĞůŽƉŵĞŶƚĂůĚĞůĂǇ PĂƐƐŽĐŝĂƟŽŶƐǁŝƚŚƉĂƌĞŶƚĂůŵĞŶƚĂů
ŚĞĂůƚŚĂŶĚĨĂŵŝůǇĨƵŶĐƟŽŶŝŶŐ. J Intellect Disabil Res. 2006; 50:874-82. | 
Aritcle | PubMed 
24. DĐ^ƚĂǇZ> ?dƌĞŵďĂƚŚĂŶĚŝƐƐĂŶĂǇĂŬĞ ?^ƚƌĞƐƐĂŶĚĨĂŵŝůǇƋƵĂůŝƚǇŽĨ
ůŝĨĞŝŶƉĂƌĞŶƚƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐŵƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ PƉĂƌĞŶƚŐĞŶĚĞƌ
ĂŶĚƚŚĞĚŽƵďůĞyŵŽĚĞů. :ƵƟƐŵĞǀŝƐŽƌĚ. 2014; 44:3101-18. | 
Aritcle | PubMed 
25. WĂǇŶƚĞƌ: ?ZŝůĞǇ ?ĞĂŵŝƐŚt ?ĂǀŝĞƐDĂŶĚDŝůĨŽƌĚd ?dŚĞĚŽƵďůĞ
yŵŽĚĞůŽĨĨĂŵŝůǇĂĚĂƉƚĂƟŽŶŝŶĨĂŵŝůŝĞƐŽĨĂĐŚŝůĚǁŝƚŚĂŶĂƵƟƐŵ
ƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌĂƩĞŶĚŝŶŐĂŶƵƐƚƌĂůŝĂŶĞĂƌůǇŝŶƚĞƌǀĞŶƟŽŶƐĞƌǀŝĐĞ. 
ZĞƐĞĂƌĐŚŝŶƵƟƐŵ^ƉĞĐƚƌƵŵŝƐŽƌĚĞƌƐ. 2013; 7:1183-95. 
26. ŝƐĞŶŚŽǁĞƌ ?ůĂĐŚĞƌ:ĂŶĚĂŬĞƌ> ?DŽƚŚĞƌƐ ?ƉĞƌĐĞŝǀĞĚƉŚǇƐŝĐĂů
ŚĞĂůƚŚĚƵƌŝŶŐĞĂƌůǇĂŶĚŵŝĚĚůĞĐŚŝůĚŚŽŽĚ PƌĞůĂƟŽŶƐǁŝƚŚĐŚŝůĚ
ĚĞǀĞůŽƉŵĞŶƚĂůĚĞůĂǇĂŶĚďĞŚĂǀŝŽƌƉƌŽďůĞŵƐ. Res Dev Disabil. 2013; 
34:1059-68. | Aritcle | PubMed Abstract | PubMed FullText
27. ,ĂƌǀĞǇ:D ?K ?ĂůůĂŐŚĂŶD:ĂŶĚsŝŶĞƐ ?WƌĞǀĂůĞŶĐĞŽĨŵĂƚĞƌŶĂů
ĚĞƉƌĞƐƐŝŽŶĂŶĚŝƚƐƌĞůĂƟŽŶƐŚŝƉƚŽ>ƐŬŝůůƐŝŶĐŚŝůĚƌĞŶǁŝƚŚ
ĚĞǀĞůŽƉŵĞŶƚĂůĚĞůĂǇ. J Paediatr Child Health. 1997; 33:42-6. | Aritcle | 
PubMed 
28. ĂŐŚĚĂĚůŝ ?WƌǇZ ?DŝĐŚĞůŽŶĂŶĚZĂƩĂǌ ?/ŵƉĂĐƚŽĨĂƵƟƐŵŝŶ
ĂĚŽůĞƐĐĞŶƚƐŽŶƉĂƌĞŶƚĂůƋƵĂůŝƚǇŽĨůŝĨĞ. Qual Life Res. 2014; 23:1859-68. 
| Aritcle | PubMed 
29. :ŝ ?ŚĂŽ/ ?dƵƌŶĞƌ ?^ƵŶD ?zŝZĂŶĚdĂŶŐ^ ?WƌĞĚŝĐƚŽƌƐŽĨŚĞĂůƚŚ ?ƌĞůĂƚĞĚ
ƋƵĂůŝƚǇŽĨůŝĨĞŝŶŚŝŶĞƐĞĐĂƌĞŐŝǀĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐŵƐƉĞĐƚƌƵŵ
ĚŝƐŽƌĚĞƌƐ PĂĐƌŽƐƐ ?ƐĞĐƟŽŶĂůƐƚƵĚǇ. Arch Psychiatr Nurs. 2014; 28:327-32. 
| Aritcle | PubMed 
30. /ŶŐĞƌƐŽůů ?DĞǇĞƌ<ĂŶĚĞĐŬĞƌDt ?/ŶĐƌĞĂƐĞĚƌĂƚĞƐŽĨĚĞƉƌĞƐƐĞĚ
ŵŽŽĚŝŶŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚ^ĂƐƐŽĐŝĂƚĞĚǁŝƚŚƚŚĞƉƌĞƐĞŶĐĞŽĨ
ƚŚĞďƌŽĂĚĞƌĂƵƟƐŵƉŚĞŶŽƚǇƉĞ. ƵƟƐŵZĞƐ. 2011; 4:143-8. | Aritcle | 
PubMed 
31. ĂďůŽƚƐŬǇ ?ƌĂĚƐŚĂǁWĂŶĚ^ƚƵĂƌƚ ?dŚĞĂƐƐŽĐŝĂƟŽŶďĞƚǁĞĞŶ
ŵĞŶƚĂůŚĞĂůƚŚ ?ƐƚƌĞƐƐ ?ĂŶĚĐŽƉŝŶŐƐƵƉƉŽƌƚƐŝŶŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚ
ĂƵƟƐŵƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌƐ. :ƵƟƐŵĞǀŝƐŽƌĚ. 2013; 43:1380-93. | 
Aritcle | PubMed 
32. ^ ĐŚŝĞǀĞ> ?ŽƵůĞƚ^> ?<ŽŐĂŶD ?zĞĂƌŐŝŶ ?ůůƐŽƉƉD ?ŽǇůĞ ?sŝƐƐĞƌ
^E ?ůƵŵďĞƌŐ^:ĂŶĚZŝĐĞ ?WĂƌĞŶƟŶŐĂŐŐƌĂǀĂƟŽŶĂŶĚĂƵƟƐŵƐƉĞĐƚƌƵŵ
ĚŝƐŽƌĚĞƌƐ P ? ? ? ?EĂƟŽŶĂů^ƵƌǀĞǇŽĨŚŝůĚƌĞŶ ?Ɛ,ĞĂůƚŚ. Disabil Health J. 
2011; 4:143-52. | Aritcle | PubMed 
33. DƵŐŶŽ ?ZƵƚĂ> ? ?ƌƌŝŐŽs'ĂŶĚDĂǌǌŽŶĞ> ?/ŵƉĂŝƌŵĞŶƚŽĨƋƵĂůŝƚǇ
ŽĨůŝĨĞŝŶƉĂƌĞŶƚƐŽĨĐŚŝůĚƌĞŶĂŶĚĂĚŽůĞƐĐĞŶƚƐǁŝƚŚƉĞƌǀĂƐŝǀĞ
ĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐŽƌĚĞƌ. Health Qual Life Outcomes. 2007; 5:22. | Aritcle 
| PubMed Abstract | PubMed FullText
34. DŽŶƚĞƐ'ĂŶĚ,ĂůƚĞƌŵĂŶ:^ ?WƐǇĐŚŽůŽŐŝĐĂůĨƵŶĐƟŽŶŝŶŐĂŶĚĐŽƉŝŶŐ
ĂŵŽŶŐŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐŵ PĂƉŽƉƵůĂƟŽŶ ?ďĂƐĞĚƐƚƵĚǇ. 
Pediatrics. 2007; 119:e1040-6. | Aritcle | PubMed 
35. >ůĞǁĞůůǇŶ' ?DĐŽŶŶĞůů ?'ĞƚŚŝŶŐ> ?ĂŶƚZĂŶĚ<ĞŶĚŝŐ, ?,ĞĂůƚŚ
ƐƚĂƚƵƐĂŶĚĐŽƉŝŶŐƐƚƌĂƚĞŐŝĞƐĂŵŽŶŐŽůĚĞƌƉĂƌĞŶƚ ?ĐĂƌĞƌƐŽĨĂĚƵůƚƐǁŝƚŚ
ŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƟĞƐŝŶĂŶƵƐƚƌĂůŝĂŶƐĂŵƉůĞ. Res Dev Disabil. 2010; 
31:1176-86. | Aritcle | PubMed 
36. KůƐƐŽŶDĂŶĚ,ǁĂŶŐW ?ĞƉƌĞƐƐŝŽŶŝŶŵŽƚŚĞƌƐĂŶĚĨĂƚŚĞƌƐŽĨĐŚŝůĚƌĞŶ
ǁŝƚŚŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƚǇ. J Intellect Disabil Res. 2001; 45:535-43. | 
Aritcle | PubMed 
37. ĂůĚǁĞůů: ?ŽŶƐƵŵĞƌ ?ĚŝƌĞĐƚĞĚƐƵƉƉŽƌƚƐ PĞĐŽŶŽŵŝĐ ?ŚĞĂůƚŚ ?ĂŶĚƐŽĐŝĂů
ŽƵƚĐŽŵĞƐĨŽƌĨĂŵŝůŝĞƐ. Ment Retard. 2006; 44:405-17. | Aritcle | PubMed 
38. ĂŶƚǁĞůů: ?DƵůĚŽŽŶKdĂŶĚ'ĂůůĂŐŚĞƌ^ ?^ŽĐŝĂůƐƵƉƉŽƌƚĂŶĚŵĂƐƚĞƌǇ
ŝŶŇƵĞŶĐĞƚŚĞĂƐƐŽĐŝĂƟŽŶďĞƚǁĞĞŶƐƚƌĞƐƐĂŶĚƉŽŽƌƉŚǇƐŝĐĂůŚĞĂůƚŚŝŶ
ƉĂƌĞŶƚƐĐĂƌŝŶŐĨŽƌĐŚŝůĚƌĞŶǁŝƚŚĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐĂďŝůŝƟĞƐ. Res Dev 
Disabil. 2014; 35:2215-23. | Aritcle | PubMed 
39. ŵĞƌƐŽŶ ?DĐƵůůŽĐŚ ?'ƌĂŚĂŵ, ?ůĂĐŚĞƌ: ?>ůǁĞůůǇŶ'DĂŶĚ,ĂƩŽŶ
C.^ŽĐŝŽĞĐŽŶŽŵŝĐĐŝƌĐƵŵƐƚĂŶĐĞƐĂŶĚƌŝƐŬŽĨƉƐǇĐŚŝĂƚƌŝĐĚŝƐŽƌĚĞƌƐĂŵŽŶŐ
ƉĂƌĞŶƚƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĞĂƌůǇĐŽŐŶŝƟǀĞĚĞůĂǇ. Am J Intellect Dev Disabil. 
Fairthorne et al., Journal of Autism 2017,  
http://www.hoajonline.com/journals/pdf/2054-992X-4-2.pdf
8
doi: 
2010; 115:30-42. | Aritcle | PubMed 
40. ^ ŝŶŐŚŝW ?'ŽǇĂů> ?WĞƌƐŚĂĚ ?^ŝŶŐŚŝ^ĂŶĚtĂůŝĂE ?WƐǇĐŚŽƐŽĐŝĂů
ƉƌŽďůĞŵƐŝŶĨĂŵŝůŝĞƐŽĨĚŝƐĂďůĞĚĐŚŝůĚƌĞŶ. Br J Med Psychol. 1990;  ? ? ?Wƚ
2):173-82. | PubMed 
41. ĂƌĚĂƐ>ĂŶĚŚŵĂĚDD ?WƐǇĐŚŽƐŽĐŝĂůĐŽƌƌĞůĂƚĞƐŽĨƉĂƌĞŶƟŶŐĂĐŚŝůĚ
ǁŝƚŚĂƵƟƐƟĐĚŝƐŽƌĚĞƌ. J Nurs Res. 2014; 22:183-91. | Aritcle | PubMed 
42. Hoppes K and Harris S. WĞƌĐĞƉƟŽŶƐŽĨĐŚŝůĚĂƩĂĐŚŵĞŶƚĂŶĚŵĂƚĞƌŶĂů
ŐƌĂƟĮĐĂƟŽŶŝŶŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐŵĂŶĚŽǁŶƐǇŶĚƌŽŵĞ. 
Journal of Clinical Child Psychology. 1990; 19:365-70. 
43. ŽƌƌŝĐĞDĂŶĚ'ůŝĚĚĞŶ>D ?dŚĞŽǁŶƐǇŶĚƌŽŵĞĂĚǀĂŶƚĂŐĞ PĨĂĐƚŽƌ
ĮĐƟŽŶ ? Am J Intellect Dev Disabil. 2009; 114:254-68. | Aritcle | PubMed 
44. Werner S and Shulman C.ŽĞƐƚǇƉĞŽĨĚŝƐĂďŝůŝƚǇŵĂŬĞĂĚŝīĞƌĞŶĐĞŝŶ
ĂĸůŝĂƚĞƐƟŐŵĂĂŵŽŶŐĨĂŵŝůǇĐĂƌĞŐŝǀĞƌƐŽĨŝŶĚŝǀŝĚƵĂůƐǁŝƚŚĂƵƟƐŵ ?
ŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƚǇŽƌƉŚǇƐŝĐĂůĚŝƐĂďŝůŝƚǇ ? J Intellect Disabil Res. 2015; 
59:272-83. | Aritcle | PubMed 
45. <ĞůƐŽd ?&ƌĞŶĐŚĂŶĚ&ĞƌŶĂŶĚĞǌD ?^ƚƌĞƐƐĂŶĚĐŽƉŝŶŐŝŶƉƌŝŵĂƌǇ
ĐĂƌĞŐŝǀĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂĚŝƐĂďŝůŝƚǇ PĂƋƵĂůŝƚĂƟǀĞƐƚƵĚǇƵƐŝŶŐƚŚĞ
>ĂǌĂƌƵƐĂŶĚ&ŽůŬŵĂŶWƌŽĐĞƐƐDŽĚĞůŽĨŽƉŝŶŐ. Journal of Research in 
^ƉĞĐŝĂůĚƵĐĂƟŽŶĂůEĞĞĚƐ. 2005; 5:3-10. 
46. Ğ'ƌĂĐĞ ?,ŽīŵĂŶ ?,ƵƚƐŽŶdĂŶĚ<ŽůŽďĞd ?&ĂŵŝůŝĞƐ ?ĞǆƉĞƌŝĞŶĐĞƐĂŶĚ
ŽĐĐƵƉĂƟŽŶƐĨŽůůŽǁŝŶŐƚŚĞĚŝĂŐŶŽƐŝƐŽĨĂƵƟƐŵ. :ŽƵƌŶĂůŽĨKĐĐƵƉĂƟŽŶĂů
Science. 2014; 21:309-21. | Aritcle 
47. >ĞŶŚĂƌĚt ?ƌĞŝƚĞŶďĂĐŚ ?ďĞƌƚ, ?^ĐŚŝŶĚĞůŚĂƵĞƌ ?ĞƵƚƐĐŚĞƌ,:ĂŶĚ
Henn W.WƐǇĐŚŽůŽŐŝĐĂůďĞŶĞĮƚŽĨĚŝĂŐŶŽƐƟĐĐĞƌƚĂŝŶƚǇĨŽƌŵŽƚŚĞƌƐŽĨ
ĐŚŝůĚƌĞŶǁŝƚŚĚŝƐĂďŝůŝƟĞƐ PůĞƐƐŽŶƐĨƌŽŵŽǁŶƐǇŶĚƌŽŵĞ. Am J Med 
Genet A. 2005;  ? ? ?:170-5. | Aritcle | PubMed 
48. >ŝŶŐĞŶD ?ůďĞƌƐ> ?ŽƌĐŚĞƌƐD ?,ĂĂƐƐ^ ?'ĂƌƚŶĞƌ: ?^ĐŚƌŽĚĞƌ^ ?'ŽůĚďĞĐŬ
> ?ǀŽŶ<ƌŝĞƐZ ?ƌŽĐŬŵĂŶŶ<ĂŶĚŝƌŶ ?KďƚĂŝŶŝŶŐĂŐĞŶĞƟĐĚŝĂŐŶŽƐŝƐ
ŝŶĂĐŚŝůĚǁŝƚŚĚŝƐĂďŝůŝƚǇ PŝŵƉĂĐƚŽŶƉĂƌĞŶƚĂůƋƵĂůŝƚǇŽĨůŝĨĞ. Clin Genet. 
2016; 89:258-66. | Aritcle | PubMed 
49. >ŽƐŚD ?ĚŽůƉŚƐZ ?WŽĞD ?ŽƵƚƵƌĞ^ ?WĞŶŶ ?ĂƌĂŶĞŬ'dĂŶĚWŝǀĞŶ: ?
EĞƵƌŽƉƐǇĐŚŽůŽŐŝĐĂůƉƌŽĮůĞŽĨĂƵƟƐŵĂŶĚƚŚĞďƌŽĂĚĂƵƟƐŵƉŚĞŶŽƚǇƉĞ. 
Arch Gen Psychiatry. 2009; 66:518-26. | Aritcle | PubMed Abstract | 
PubMed FullText
50. ŝƐŚŽƉs ?DĂǇďĞƌǇD ?DĂůĞǇ ?tŽŶŐ ?,ŝůůtĂŶĚ,ĂůůŵĂǇĞƌ: ?hƐŝŶŐ
ƐĞůĨ ?ƌĞƉŽƌƚƚŽŝĚĞŶƟĨǇƚŚĞďƌŽĂĚƉŚĞŶŽƚǇƉĞŝŶƉĂƌĞŶƚƐŽĨĐŚŝůĚƌĞŶ
ǁŝƚŚĂƵƟƐƟĐƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌƐ PĂƐƚƵĚǇƵƐŝŶŐƚŚĞƵƟƐŵ ?^ƉĞĐƚƌƵŵ
YƵŽƟĞŶƚ. J Child Psychol Psychiatry. 2004; 45:1431-6. | Aritcle | PubMed 
51. ,ƵƌůĞǇZ^ ?>ŽƐŚD ?WĂƌůŝĞƌD ?ZĞǌŶŝĐŬ:^ĂŶĚWŝǀĞŶ: ?dŚĞďƌŽĂĚĂƵƟƐŵ
ƉŚĞŶŽƚǇƉĞƋƵĞƐƟŽŶŶĂŝƌĞ. :ƵƟƐŵĞǀŝƐŽƌĚ. 2007; 37:1679-90. | 
Aritcle | PubMed 
52. /ŶŐĞƌƐŽůů ?DĞǇĞƌ<ĂŶĚĞĐŬĞƌDt ?/ŶĐƌĞĂƐĞĚƌĂƚĞƐŽĨĚĞƉƌĞƐƐĞĚ
ŵŽŽĚŝŶŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚ^ĂƐƐŽĐŝĂƚĞĚǁŝƚŚƚŚĞƉƌĞƐĞŶĐĞŽĨ
ƚŚĞďƌŽĂĚĞƌĂƵƟƐŵƉŚĞŶŽƚǇƉĞ. ƵƟƐŵZĞƐ. 2011; 4:143-8. | Aritcle | 
PubMed 
53. 'ƌŝĸƚŚ'D ?,ĂƐƟŶŐƐZW ?EĂƐŚ^ĂŶĚ,ŝůů ?hƐŝŶŐŵĂƚĐŚĞĚŐƌŽƵƉƐƚŽ
ĞǆƉůŽƌĞĐŚŝůĚďĞŚĂǀŝŽƌƉƌŽďůĞŵƐĂŶĚŵĂƚĞƌŶĂůǁĞůů ?ďĞŝŶŐŝŶĐŚŝůĚƌĞŶ
ǁŝƚŚŽǁŶƐǇŶĚƌŽŵĞĂŶĚĂƵƟƐŵ. :ƵƟƐŵĞǀŝƐŽƌĚ. 2010; 40:610-9. 
| Aritcle | PubMed 
54. ŽǇĚ ?ǆĂŵŝŶŝŶŐƚŚĞƌĞůĂƟŽŶƐŚŝƉďĞƚǁĞĞŶƐƚƌĞƐƐĂŶĚůĂĐŬŽĨƐŽĐŝĂů
ƐƵƉƉŽƌƚŝŶŵŽƚŚĞƌƐŽĨĐŚŝůĚƌĞŶǁŝƚŚĂƵƟƐŵ. &ŽĐƵƐŽŶƵƟƐŵĂŶĚKƚŚĞƌ
ĞǀĞůŽƉŵĞŶƚĂůŝƐĂďŝůŝƟĞƐ. 2002; 17:208-15. 
55. ,ŽůƚǌŵĂŶĂŶĚƉƐƚĞŝŶ: ?dŚĞŵŽůĞĐƵůĂƌŐĞŶĞƟĐƐŽĨŽǁŶƐǇŶĚƌŽŵĞ. 
/Ŷ P&ƌŝĞĚŵĂŶŶd ?ĞĚŝƚŽƌ ?DŽůĞĐƵůĂƌ'ĞŶĞƟĐDĞĚŝĐŝŶĞ ? ? ?^ĂŶŝĞŐŽ ?
ĂůŝĨŽƌŶŝĂ PĐĂĚĞŵŝĐWƌĞƐƐ ? ? ? ? ? ? ? ? ? ? ? ? ?
56. ,ŝŐŐŝŶƐ: ?ĂŝůĞǇ^ZĂŶĚWĞĂƌĐĞ: ?&ĂĐƚŽƌƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚĨƵŶĐƟŽŶŝŶŐ
ƐƚǇůĞĂŶĚĐŽƉŝŶŐƐƚƌĂƚĞŐŝĞƐŽĨĨĂŵŝůŝĞƐǁŝƚŚĂĐŚŝůĚǁŝƚŚĂŶĂƵƟƐŵ
ƐƉĞĐƚƌƵŵĚŝƐŽƌĚĞƌ. ƵƟƐŵ. 2005; 9:125-37. | Aritcle | PubMed 
57. ,ĂƐƟŶŐƐZW ?WĂƌĞŶƚĂůƐƚƌĞƐƐĂŶĚďĞŚĂǀŝŽƵƌƉƌŽďůĞŵƐŽĨĐŚŝůĚƌĞŶǁŝƚŚ
ĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐĂďŝůŝƚǇ. Journal of Intellectual and Developmental 
Disability. 2002; 27:149-60. 
58. tŽŽĚŐĂƚĞZ> ?ƚĞĂŚĂŶĚ^ĞĐĐŽ> ?>ŝǀŝŶŐŝŶĂǁŽƌůĚŽĨŽƵƌŽǁŶ PƚŚĞ
ĞǆƉĞƌŝĞŶĐĞŽĨƉĂƌĞŶƚƐǁŚŽŚĂǀĞĂĐŚŝůĚǁŝƚŚĂƵƟƐŵ. Qual Health Res. 
2008; 18:1075-83. | Aritcle | PubMed 
59. 'ƌĂǇ ? RǀĞƌǇďŽĚǇũƵƐƚĨƌĞĞǌĞƐ. ǀĞƌǇďŽĚǇŝƐũƵƐƚĞŵďĂƌƌĂƐƐĞĚ ? P&Ğůƚ
ĂŶĚĞŶĂĐƚĞĚƐƟŐŵĂĂŵŽŶŐƉĂƌĞŶƚƐŽĨĐŚŝůĚƌĞŶǁŝƚŚŚŝŐŚĨƵŶĐƟŽŶŝŶŐ
ĂƵƟƐŵ. Sociology of Health and Illness. 24:734-49. 
60. Douma JC, Dekker MC and Koot HM.^ƵƉƉŽƌƟŶŐƉĂƌĞŶƚƐŽĨǇŽƵƚŚƐǁŝƚŚ
ŝŶƚĞůůĞĐƚƵĂůĚŝƐĂďŝůŝƟĞƐĂŶĚƉƐǇĐŚŽƉĂƚŚŽůŽŐǇ. J Intellect Disabil Res. 
2006; 50:570-81. | Aritcle | PubMed 
61. tĂƚƐŽŶ^> ?,ĂǇĞƐ^ĂŶĚZĂĚĨŽƌĚ ?WĂǌ ?ŝĂŐŶŽƐĞŵĞƉůĞĂƐĞ ? 弃PƌĞǀŝĞǁ
ŽĨƌĞƐĞĂƌĐŚĂďŽƵƚƚŚĞũŽƵƌŶĞǇĂŶĚŝŶŝƟĂůŝŵƉĂĐƚŽĨƉĂƌĞŶƚƐƐĞĞŬŝŶŐ
ĂĚŝĂŐŶŽƐŝƐŽĨĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐĂďŝůŝƚǇĨŽƌƚŚĞŝƌĐŚŝůĚ. /ŶƚĞƌŶĂƟŽŶĂů
ƌĞǀŝĞǁŽĨƌĞƐĞĂƌĐŚŝŶĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐĂďŝůŝƟĞƐ. 2011; 41:31-72. 
62. dĂŽ: ?sĂŶƐĐŚ, ?,ĂŐĞĚŽƌŶ ?'ƌĞŝǁĞD ?,ŽīŵĂŶŶ< ?DŽƐĞƌ ?ZĂǇŶĂƵĚ
D ?^ƉĞƌŶĞƌ: ?&ƌǇŶƐ:W ?^ĐŚǁŝŶŐĞƌ ?'ĞĐǌ: ?ZŽƉĞƌƐ,,ĂŶĚ<ĂůƐĐŚĞƵĞƌ
VM.DƵƚĂƟŽŶƐŝŶƚŚĞy ?ůŝŶŬĞĚĐǇĐůŝŶ ?ĚĞƉĞŶĚĞŶƚŬŝŶĂƐĞ ?ůŝŬĞ ?
 ?<> ? ?^d< ? ?ŐĞŶĞĂƌĞĂƐƐŽĐŝĂƚĞĚǁŝƚŚƐĞǀĞƌĞŶĞƵƌŽĚĞǀĞůŽƉŵĞŶƚĂů
ƌĞƚĂƌĚĂƟŽŶ. Am J Hum Genet. 2004; 75:1149-54. | Aritcle | PubMed 
Abstract | PubMed FullText
63. >ĂĐŚ>D ?<ŽŚĞŶ ?'ĂƌŶĞƌZ ?ƌĞŚĂƵƚ: ?DŝůůĞƌZ ?<ůĂƐƐĞŶ&Ă Ě
ZŽƐĞŶďĂƵŵW> ?dŚĞŚĞĂůƚŚĂŶĚƉƐǇĐŚŽƐŽĐŝĂůĨƵŶĐƟŽŶŝŶŐŽĨĐĂƌĞŐŝǀĞƌƐ
ŽĨĐŚŝůĚƌĞŶǁŝƚŚŶĞƵƌŽĚĞǀĞůŽƉŵĞŶƚĂůĚŝƐŽƌĚĞƌƐ. Disabil Rehabil. 2009; 
31:607-18. | Aritcle | PubMed 
